Select Medical (NYSE:SEM) Rating Lowered to Hold at Benchmark

Select Medical (NYSE:SEM) was downgraded by stock analysts at Benchmark from a “buy” rating to a “hold” rating in a research note issued on Monday, Marketbeat reports.

A number of other brokerages have also weighed in on SEM. Bank of America initiated coverage on shares of Select Medical in a report on Tuesday, August 20th. They set a “buy” rating and a $42.00 price objective on the stock. StockNews.com lowered shares of Select Medical from a “buy” rating to a “hold” rating in a report on Thursday, November 21st. Finally, Royal Bank of Canada boosted their target price on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $40.75.

Select Medical Price Performance

NYSE SEM opened at $21.32 on Monday. The firm’s fifty day simple moving average is $35.26 and its two-hundred day simple moving average is $35.09. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. Select Medical has a 12-month low of $20.17 and a 12-month high of $40.98. The firm has a market capitalization of $2.76 billion, a P/E ratio of 9.97, a P/E/G ratio of 1.78 and a beta of 1.42.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.07. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The business’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.46 earnings per share. Analysts forecast that Select Medical will post 2.16 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Tidal Investments LLC acquired a new position in shares of Select Medical in the third quarter worth about $286,000. Wilmington Savings Fund Society FSB acquired a new position in shares of Select Medical in the third quarter worth about $81,000. Virtu Financial LLC acquired a new position in shares of Select Medical in the third quarter worth about $210,000. Geode Capital Management LLC raised its position in shares of Select Medical by 2.0% in the third quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock worth $85,180,000 after acquiring an additional 46,880 shares during the period. Finally, Barclays PLC raised its position in shares of Select Medical by 396.0% in the third quarter. Barclays PLC now owns 192,357 shares of the health services provider’s stock worth $6,707,000 after acquiring an additional 153,576 shares during the period. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.